A phase II clinical trial of the single agent oral FGF receptor inhibitor AZD4547 as second of third line therapy in malignant pleural mesothelioma: final results of the FRAME study

Wei-Sen Lam, Anna K. Nowak, Fred Chen, Sanjeevan Muruganandan, Sukyana Arunachalam, Melvin Loong, Michael Millward, Kevin Murray, Cathy Read, Jenette Creaney, Gary Y. C. Lee

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)84-84
Number of pages1
JournalAsia-Pacific Journal of Clinical Oncology
Publication statusPublished - Nov 2018

Cite this